Access Institutional-Quality Private Markets
Apogem Evergreen Fund
Aims to generate long-term capital appreciation through broad exposure to private equity investments.
Explore our Alternative Solutions
- at NAV
- W/ sales charge (MF)/mkt price (ETF)
| Morningstar Rating Risk Adjusted Returns As of 09/30/2026 | Average Annual Total Returns As of 09/30/2026 As of 09/30/2026 | ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Symbol | Name | Asset Class | Share Class | Overall Rating | Category | Funds in Category | YTD | 1Y | 3Y | 5Y | 10Y | SI | Incept. Date |
| MNA | NYLIM Merger Arbitrage ETF | Alternatives | - |
|
Event Driven | 45 | 2.39 2.39 - - | 2.39 2.39 2.59 2.59 | 5.53 5.53 5.68 5.68 | 2.50 2.50 2.55 2.55 | 2.73 2.73 2.75 2.75 | 2.74 2.74 2.75 2.75 | 11/17/2009 |
| QAI | NYLIM Hedge Multi-Strategy Tracker ETF | Alternatives | - |
|
Multistrategy | 106 | 7.81 7.81 - - | 8.92 8.92 8.77 8.77 | 9.00 9.00 8.99 8.99 | 4.63 4.63 4.61 4.61 | 3.71 3.71 3.70 3.70 | 3.50 3.50 3.49 3.49 | 03/25/2009 |
NOTE: On October 1, 2026, Bow River Advisers and its employees fully integrated with Apogem Capital, and the Bow River Capital Evergreen Fund became the Apogem Evergreen Fund. This change to the Fund’s management was approved by the Fund’s shareholders on August 31, 2026. There have been no other changes to the investment strategy, objectives, or terms of the Fund, and the team remains in place, now as employees of Apogem Capital. All references in materials to Bow River Advisers or Bow River Capital no longer apply and will change to Apogem Evergreen and Apogem Capital.
www.apogemevergreen.com Read the prospectus carefully. An offer can only be made by the prospectus and only in jurisdictions in which such an offer would be lawful. The prospectus contains important information concerning risk factors and other material aspects of the Fund to carefully consider and must be read carefully before a decision to invest is made. An investor should consider the Fund’s investment objectives, risks, charges and expenses before investing. This and other important information can be found in the Fund’s prospectus. To obtain a prospectus, please visit www.apogemevergreen.com before investing.
Interval Fund Risk Disclosure: The Funds are interval closed-end funds. Investing in interval closed-end funds involves risk, including the possible loss of principal. Interval funds are generally considered illiquid investments and do not provide investors with daily liquidity. Although the Funds will make periodic offers to repurchase a portion of their outstanding shares, there is no guarantee that shareholders will be able to sell all of their tendered shares during a particular repurchase offer. If a repurchase offer is oversubscribed, shares may be repurchased on a pro rata basis, and investors may be unable to liquidate all or a given percentage of their investment during a particular repurchase offer. Investors should carefully consider a Fund’s investment objectives, risks, charges and expenses before investing.
Institutional quality private equity refers to a portfolio of investment exposures that are typically only available to institutional investors as well as one that provides broad exposure by vintage year, sector, geography and sponsor.
General Disclosure: This material is not intended to be a recommendation or investment advice and does not constitute a solicitation to buy, sell or hold a security or an investment strategy. The information provided does not consider the specific objectives or circumstances of any particular investor or suggest any specific course of action. Investment decisions should be made based on an investor’s objectives and circumstances and in consultation with his or her financial professional.
Performance data quoted represents past performance. Past performance is no guarantee of future results. Due to market volatility, current performance may be less or higher than the figures shown. Investment return and principal value will fluctuate so that upon redemption, shares may be worth more or less than their original cost. Performance figures for all Funds reflect contractual waivers and/or expense limitations, without which total returns may have been lower. These limitations may be modified or terminated only with Board approval.
The Morningstar Rating™ for funds, or "star rating", is calculated for managed products (including mutual funds, variable annuity and variable life subaccounts, exchange-traded funds, closed-end funds, and separate accounts) with at least a three-year history. Exchange-traded funds and open-ended mutual funds are considered a single population for comparative purposes. It is calculated based on a Morningstar Risk-Adjusted Return measure that accounts for variation in a managed product's monthly excess performance, placing more emphasis on downward variations and rewarding consistent performance (this does not include the effects of sales charges, loads, and redemption fees). The top 10% of products in each product category receive 5stars, the next 22.5% receive 4 stars, the next 35% receive 3 stars, the next 22.5% receive 2 stars, and the bottom 10% receive 1 star. The Overall Morningstar Rating for a managed product is derived from a weighted average of the performance figures associated with its three-, five-, and 10-year (if applicable) Morningstar Rating metrics. The weights are: 100% three-year rating for 36-59 months of total returns, 60% five-year rating/40% three-year rating for 60-119 months of total returns, and 50% 10-year rating/30% five-year rating/20% three-year rating for 120 or more months of total returns. While the 10-year overall star rating formula seems to give the most weight to the 10-year period, the most recent three-year period actually has the greatest impact because it is included in all three rating periods.
Click on the product name for the most recent overall risk-adjusted Morningstar ratings shown above, including ratings by share class and time period and the number of funds in each category. The Fund page also includes the prospectus, investment objectives, performance, risk and other important information.